Used in research for treating dyslipidemia and hypercholesterolemia by selectively targeting the thyroid hormone receptor beta (TRβ). It helps lower low-density lipoprotein (LDL) cholesterol and triglycerides without significantly affecting heart rate or bone metabolism, which are common side effects of systemic thyroid hormone activation. Investigated for potential use in non-alcoholic steatohepatitis (NASH) due to its effects on liver metabolism and fat reduction. Shows promise in improving markers of liver function and reducing hepatic fat accumulation in preclinical and early clinical studies.